Direct Aortic Evolut R Implantation as Valve-In-Valve in a Patient Affected by Leriche Syndrome
Journal: Journal of Cardiovascular Medicine and Cardiology (Vol.3, No. 2)Publication Date: 2016-12-15
Authors : Pierre Dahdah Giuseppe Bruschi; Victor Jebara;
Page : 038-040
Keywords : Transcatheter valve implantation; Surgery; Aortic; Aortic valve disease;
Abstract
Transcatheter aortic valve implantation (TAVI) is an appropriate therapy to treat elderly patients with severe aortic stenosis considered high-risk surgical candidates. The safety and effectiveness of TAVI have been demonstrated in numerous observational clinical studies, national registries and also in controlled randomized trial [1,2].
Other Latest Articles
- Hurdles for Starting Ministernotomy Aortic Valve Replacement Program
- Aortic Valve Thrombosis in Antiphospholipid Syndrome Causing Coronary Artery Embolic Disease
- Subclavian Artery Pseudoaneurysm Secondary to Accidental Stone Chip Injury and its Excision
- Historical Evolution of Surgery for Transposition of Great Arteries (TGA)
- Long Segment Left Anterior Descending Endarterectomy [10 cm] and its Reconstruction Using Left Internal Thoracic Artery
Last modified: 2018-09-05 14:53:18